Lecture 3: CV Pathophysiology I Flashcards
abnormally high hematocrit
polycythemia vera
What causes polycythemia vera?
- overproduction of blood cell cursors by bone marrow
- genetic mutation
How is polycythemia vera treated? What are the complications?
- regular phlebotomy
- increases risk of abnormal clotting, enlargement of spleen, and damage to bone marrow
fraction of blood volume that is erythrocytes (normal = 42-45%)
hematocrit
lower than normal hematocrit
anemia
What can cause anemia?
- blood loss (heavy menstrual periods, hemorrhage, internal bleeding)
- hemolysis (via infectious/autoimmune disease)
- nutritional deficiencies (iron, vitamin B12)
- defects in regulation of blood cell production
rupturing of red blood cells
hemolysis
too many white blood cells
leukemia
Why is leukemia damaging?
- tends to go hand in hand with anemia
- immune defense does not function well; vulnerable to infection
too few white blood cells
AIDS, immune deficiency, chemotherapy
Why are low levels of leukocytes dangerous?
prone to infection
What happens during primary hemostasis?
- vasoconstriction and formation of a platelet plug
- tissue damage exposes collagen
- platelets adhere to collagen via von Willebrand factor (vWF)
- fibrinogen links aggregating platelets –> plug
released from platelets; causes vasoconstriction
thromboxane A2
What happens during secondary hemostasis?
- transforms blood into a solid gel (clot/thrombus)
- clot surrounds and reinforces platelet plug
- blood solidifies at site of wound
How is the extrinsic pathway of hemostasis activated?
- triggered by exposure of blood to sub-endothelial cells that produce tissue factor
- some cells only produce tissue factor in response to damage
- monocytes/macrophages produce tissue factor in response to inflammation
- TF can also be found in circulating blood and endothelial cells even in the absence of damage
How is the intrinsic pathway of hemostasis activated?
activated by exposure to collagen
irreversibly binds to thrombin, preventing it from catalyzing the formation of fibrin
antithrombin
What about endothelial cells increases the effectiveness of antithrombin?
surface of endothelial cells contains heparin sulfate which enhances antithrombin 1000 fold
inactivates key acceleration factors in the coagulation pathway; second protein enhances the first
Protein C and Protein S
an endothelial receptor that binds thrombin and activates protein C
thrombomodulin
inactivates the complex of tissue factor
TFPI (Tissue Factor Protein Inhibitor)
What inhibits thrombin via negative feedback to limit clotting?
fibrin
a protein that cleaves the protein plasminogen to plasmin, which in turn enzymatically breaks down fibrin clots
tPA (tissue plasminogen activator)
inhibits platelet activation and aggravation; causes vasodilation
prostacyclin
inhibits platelet activation and causes vasodilation
nitric oxide
3 factors that help resolve blood clots:
- tPA
- prostacyclin
- nitric oxide
Factors that inhibit clotting:
- Antithrombin
- Protein C/Protein S
- Thrombomodulin
- TFPI
- Fibrin
rare genetic disorder; sex-linked; inability to produce vWF
hemophilia